Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Gamma secretase inhibitor MRK-003 effect on pancreatic ductal adenocarcinoma tumor xenografts
PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet
The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models
PubMed Full text in PMC Similar studies Analyze with GEO2R
Discovery of biomarkers predictive of GSI response in triple negative breast cancer and adenoid cystic carcinoma
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
Profiling of human cancer breast cell lines (Affymetrix)
Expression data from AsPC1 cells treated with ICG-001
Beta-catenin depletion effect on pancreatic cancer cell line
CREB-Binding Protein Inhibitor ICG-001 effect on pancreatic cancer cell line: time course
CDK-4 inhibitor P276-00 sensitizes Pancreatic Cancer cells to Gemcitabine induced Apoptosis
Effect of NOTCH-γ-secretase inhibitor LY3039478 therapy on patient derived xenograft (PDX) mouse model of intrahepatic cholangiocarcinoma
PubMed Full text in PMC Similar studies
Global mRNA/LncRNA expression analysis of pancreatic tumors causing type3C Diabetes Mellitus
Gemcitabine induced TIMP-1 attenuates therapy response and promotes tumour growth and liver metastasis in pancreatic cancer
PubMed Similar studies Analyze with GEO2R
Targeting multiple effector pathways in pancreatic ductal adenocarcinoma with a G-quadruplex-binding small molecule
Profiling the Panc1 pancreatic cancer cell line following Gemcitabine treatment using single cell RNA sequencing
PubMed Full text in PMC Similar studies SRA Run Selector
The NAMPT inhibitor FK866 increases metformin sensitivity in pancreatic cancer cells
Transcriptomic profiling of highly- and lowly- metastasizing pancreatic ductal carcinoma cells
PubMed Similar studies
Transcriptomic profiling of highly- and lowly- metastasizing pancreatic ductal carcinoma cells [mRNAseq shNPTX1]
Transcriptomic profiling of highly- and lowly- metastasizing pancreatic ductal carcinoma cells [mRNAseq in vivo selection]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on